Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?
Artificial intelligence could have a huge impact on drug discovery.
Machine learning and DNA methylation could open up a new realm of diagnostic possibility
Data analysis in proteomics is not fit for purpose – but here’s how we can get on track
The story behind an inflatable pill and a sensitive biomarker that pair up to improve screening for Barrett’s esophagus – and help prevent a highly aggressive cancer
Suneel Deepak Kamath
Is direct-to-consumer testing anywhere near as useful as it appears to the public – or to science?
Mary E. Spilker,
As the profile of metabolomics soars, we offer our thoughts on the future of the field.
A review of FDA data suggests that women are now better represented in clinical trials.
A woman who can identify people with Parkinson’s by smell is helping scientists pinpoint molecules
Pan Pantziarka and Gauthier Bouche
New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.
Send me the latest from The Translational Scientist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.